Recombinant oxalate degrading enzyme (OxThera)

N/A

Report date: 2022/11/25 18:10:01

Base Information

Drug NameRecombinant oxalate degrading enzyme (OxThera)
Drug Alias Name重组草酸降解酶OxazymeIxC1-62/47
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionOxalic acid inhibitors
TargetsOxalic acid
Therapy Area/IndicationsHyperoxaluria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxthera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxthera Inc
Active IndicationsN/A
Inactive IndicationsHyperoxaluria

Other Information

ATC CodeN/A
Related LinksWikipedia